Dr. Brooke Grindlinger, Chief Scientific Officer for The New York Academy of Sciences, discusses the role that philanthropy can play in supporting scientists as well as the importance of supporting girls and women in science fields.
All content for The New York Academy of Sciences is the property of The New York Academy of Sciences and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. Brooke Grindlinger, Chief Scientific Officer for The New York Academy of Sciences, discusses the role that philanthropy can play in supporting scientists as well as the importance of supporting girls and women in science fields.
Non-alcoholic fatty liver disease is set to become the most common cause of liver transplant in the coming decade. Although almost one-third of adults worldwide suffer from the condition, which is also associated with diabetes and obesity, there are currently no approved treatments. This podcast will discuss the basis of liver disease as well as several cutting edge approaches that are being developed to model the disease and speed the discovery of new therapeutics.
This podcast has been made possible with support from Emulate (https://www.emulatebio.com).
The New York Academy of Sciences
Dr. Brooke Grindlinger, Chief Scientific Officer for The New York Academy of Sciences, discusses the role that philanthropy can play in supporting scientists as well as the importance of supporting girls and women in science fields.
